[HTML][HTML] ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour …
Background Cancers with a defective DNA mismatch repair (dMMR) system contain
thousands of mutations most frequently located in monomorphic microsatellites and are …
thousands of mutations most frequently located in monomorphic microsatellites and are …
Current landscape of non-small cell lung cancer: epidemiology, histological classification, targeted therapies, and immunotherapy
O Rodak, MD Peris-Díaz, M Olbromski… - Cancers, 2021 - mdpi.com
Simple Summary The abundance and the dynamic of the studies on NSCLC require
frequent summaries of the current achievements in the field. In our review, we aimed to …
frequent summaries of the current achievements in the field. In our review, we aimed to …
[HTML][HTML] Genomic instability and cancer
Genomic instability is a characteristic of most cancer cells. It is an increased tendency of
genome alteration during cell division. Cancer frequently results from damage to multiple …
genome alteration during cell division. Cancer frequently results from damage to multiple …
Crystal structure of Δ-[Ru(bpy)2dppz]2+ bound to mismatched DNA reveals side-by-side metalloinsertion and intercalation
H Song, JT Kaiser, JK Barton - Nature chemistry, 2012 - nature.com
DNA mismatches represent a novel target in the development of diagnostics and
therapeutics for cancer, because deficiencies in DNA mismatch repair are implicated in …
therapeutics for cancer, because deficiencies in DNA mismatch repair are implicated in …
Review of histopathological and molecular prognostic features in colorectal cancer
O Marzouk, J Schofield - Cancers, 2011 - mdpi.com
Prediction of prognosis in colorectal cancer is vital for the choice of therapeutic options.
Histopathological factors remain paramount in this respect. Factors such as tumor size …
Histopathological factors remain paramount in this respect. Factors such as tumor size …
Mismatch repair pathway: molecules, functions, and role in colorectal carcinogenesis
AS Sameer, S Nissar, K Fatima - European journal of cancer …, 2014 - journals.lww.com
The microsatellite instability (MSI) pathway is one of the important mutational pathways that
play a critical role in colorectal carcinogenesis. About 15% of colorectal cancers (CRCs) are …
play a critical role in colorectal carcinogenesis. About 15% of colorectal cancers (CRCs) are …
A review of the clinical relevance of mismatch‐repair deficiency in ovarian cancer
T Pal, J Permuth‐Wey, TA Sellers - … International Journal of the …, 2008 - Wiley Online Library
Ovarian cancer ranks fifth in both cancer incidence and mortality among women in the
United States. Defects in the mismatch‐repair (MMR) pathway that arise through genetic …
United States. Defects in the mismatch‐repair (MMR) pathway that arise through genetic …
Artificial intelligence for predicting microsatellite instability based on tumor histomorphology: a systematic review
Microsatellite instability (MSI)/defective DNA mismatch repair (dMMR) is receiving more
attention as a biomarker for eligibility for immune checkpoint inhibitors in advanced …
attention as a biomarker for eligibility for immune checkpoint inhibitors in advanced …
ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability
H Abe, D Maeda, R Hino, Y Otake, M Isogai, AS Ushiku… - Virchows Archiv, 2012 - Springer
The AT-rich interactive domain 1A gene (ARID1A), which encodes one of the subunits in the
Switch/Sucrose Nonfermentable chromatin remodeling complex, carries mutations and is …
Switch/Sucrose Nonfermentable chromatin remodeling complex, carries mutations and is …
Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy
FM Smith, JV Reynolds, N Miller, RB Stephens… - European Journal of …, 2006 - Elsevier
AIMS: The prediction of sensitivity and resistance to neoadjuvant therapy has great potential
value for many tumour sites. A neoadjuvant regimen is increasingly the gold standard in …
value for many tumour sites. A neoadjuvant regimen is increasingly the gold standard in …